RECRUITING

Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data

Talk to us

Conditions

Opioid Use DisorderOpioid Useopioid overdoseopioid poisoningharm-reductionsub-acute stabilization

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study is a quasi-experimental investigation of a sub-acute stabilization center (SASC) for people who have had or are at risk for having an opioid overdose and have an encounter with Seattle Fire Department emergency medical services (EMS) in Seattle, WA. Those transported to the SASC are the intervention participants and two comparison groups will be utilized: eligible Seattle EMS patients who opt not to go to the SASC and King County residents, outside of Seattle, who meet the same eligibility criteria. A comparative interrupted time series analysis is planned to study the main effectiveness outcomes. Seattle Fire EMS will assess, refer, and arrange transport for participants to the SASC. The SASC will offer an array of services including post-overdose monitoring, utilization of buprenorphine and methadone for the treatment opioid use disorder and opioid withdrawal, linkage to ongoing care for OUD, and provision of harm reduction services and supplies. The length of stay in the SASC will be limited to less than 24 hours. A continuous process improvement (CPI) approach will monitor and refine the intervention. Characterization of the interventions will be based upon analysis of service utilization patterns over time along with interviews and surveys with stakeholders.

Official Title

Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data

Quick Facts

Study Start:2024-12-15
Study Completion:2029-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06768814

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Verbally consents to transfer of care to SASC.
  2. 2. Awake and oriented to person and place, with no significant deficits in mental status or neurological function.
  3. 3. Age \>=18
  4. 4. Patent airway and effective respirations with adequate oxygenation.
  5. 5. Stable heart rate and blood pressure, with no evidence of cardiac arrhythmias or other significant cardiovascular disfunction.
  6. 6. Vitals:
  7. * Heart rate: 45-130
  8. * Blood pressure: systolic 95-190, diastolic 50-120
  9. * Respiratory rate: 10-24
  10. * SpO2: \>92 on room air or supplemental O2 via nasal cannula.
  11. * SpO2 \<92% with supplemental O2 requires ED transfer.
  12. * EtCO2: \<50
  13. * Temperature: 95.5-100.3 F
  14. * Blood glucose (if indicated): 60-300
  15. 7. No signs of head trauma:
  16. * Dizziness or loss of balance
  17. * Blurred vision or double vision
  18. * Sensitivity to light or noise
  19. * Seizures or convulsions
  20. * Weakness or numbness in the arms or legs
  21. * Persistent or worsening headache
  22. * CSF or blood leaking from the nose or ears
  23. * Unequal pupils or pupils that are slow to react to light.
  24. 8. No signs of other traumatic injury or medical needs requiring immediate treatment.
  25. 9. No signs of respiratory infection. Screen for COVID-19. See COVID-19 Screening protocol.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Anthony S Floyd, PhD
CONTACT
206-616-7382
asfloyd@uw.edu

Principal Investigator

Caleb Banta-Green, PhD, MPH, MSW
PRINCIPAL_INVESTIGATOR
University of Washington

Study Locations (Sites)

Downtown Emergency Service Center's Overdose Recovery and Care Access Centers
Seattle, Washington, 98104
United States

Collaborators and Investigators

Sponsor: University of Washington

  • Caleb Banta-Green, PhD, MPH, MSW, PRINCIPAL_INVESTIGATOR, University of Washington

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-15
Study Completion Date2029-05-31

Study Record Updates

Study Start Date2024-12-15
Study Completion Date2029-05-31

Terms related to this study

Keywords Provided by Researchers

  • opioid overdose
  • opioid poisoning
  • harm-reduction
  • sub-acute stabilization

Additional Relevant MeSH Terms

  • Opioid Use Disorder
  • Opioid Use